Table 1.
Results of Laboratory Investigation before LEN Administration.
| Hematology | Biochemistry | Tumor marker | |||||||||||
| WBC | 5,460 | /μL | TP | 7.6 | g/dL | AFP | 113 | ng/mL | |||||
| RBC | 456×104 | /μL | Alb | 4.2 | g/dL | AFP-L3 | 61.6 | % | |||||
| Hb | 15.3 | g/dL | BUN | 17.0 | mg/dL | DCP | 843.6 | ng/mL | |||||
| PLT | 17.3×104 | /μL | Cre | 0.9 | mg/dL | ||||||||
| T-Bil | 1.0 | mg/dL | |||||||||||
| AST | 49 | IU/L | |||||||||||
| ALT | 60 | IU/L | |||||||||||
| Coagulation | LDH | 265 | IU/L | ||||||||||
| PT | 113 | % | ALP | 310 | IU/L | ||||||||
| APTT | 31.5 | s | γGTP | 185 | IU/L | ||||||||
| CRP | 1.3 | mg/dL | |||||||||||
LEN: lenvatinib, WBC: white blood cell, RBC: red blood cell, Hb: hemoglobin, PLT: platelet, PT: prothrombin time, APTT: activated partial thromboplastin time, TP: total protein, Alb: albumin, BUN: blood urea nitrogen, Cre: creatinine, T-Bil: total bilirubin, AST: aspartate aminotransferase, ALT: alanine aminotransferase, LDH: lactate dehydrogenase, ALP: alkaline phosphatase, γGTP: gamma-glutamyl transpeptidase, CRP: C-reactive protein, AFP: alpha-fetoprotein, AFP-L3: lectin-reactive alpha-fetoprotein, DCP: Des-gamma-carboxy prothrombin